{
  "openalex_id": "W1974616435",
  "doi": "https://doi.org/10.1016/0006-3223(87)90127-2",
  "title": "High-dose naltrexone therapy and dietary counseling for obesity",
  "abstract": "",
  "authors": [
    {
      "display_name": "James E. Mitchell",
      "id": "A5023250605",
      "orcid": "https://orcid.org/0000-0001-5434-6021",
      "institutions": [
        {
          "id": "I4210135252",
          "display_name": "University of Minnesota Medical Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "James E. Mitchell"
    },
    {
      "display_name": "John E. Morley",
      "id": "A5102748794",
      "orcid": "https://orcid.org/0000-0003-1104-0393",
      "institutions": [
        {
          "id": "I1322918889",
          "display_name": "United States Department of Veterans Affairs",
          "country_code": "US",
          "type": "government"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "John E. Morley"
    },
    {
      "display_name": "Alan S. Levine",
      "id": "A5109083985",
      "orcid": null,
      "institutions": [
        {
          "id": "I1322918889",
          "display_name": "United States Department of Veterans Affairs",
          "country_code": "US",
          "type": "government"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Alan S. Levine"
    },
    {
      "display_name": "Dorothy Hatsukami",
      "id": "A5113659063",
      "orcid": null,
      "institutions": [
        {
          "id": "I4210135252",
          "display_name": "University of Minnesota Medical Center",
          "country_code": "US",
          "type": "healthcare"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Dorothy Hatsukami"
    },
    {
      "display_name": "Mary C. Gannon",
      "id": "A5057857428",
      "orcid": "https://orcid.org/0000-0001-5460-2478",
      "institutions": [
        {
          "id": "I1322918889",
          "display_name": "United States Department of Veterans Affairs",
          "country_code": "US",
          "type": "government"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "Mary Gannon"
    },
    {
      "display_name": "David Pfohl",
      "id": "A5111601891",
      "orcid": null,
      "institutions": [
        {
          "id": "I1316910977",
          "display_name": "DuPont (United States)",
          "country_code": "US",
          "type": "funder"
        }
      ],
      "is_corresponding": false,
      "raw_author_name": "David Pfohl"
    }
  ],
  "publication_year": 1987,
  "publication_date": "1987-01-01",
  "type": "article",
  "cited_by_count": 105,
  "is_retracted": false,
  "is_paratext": false,
  "language": "en",
  "source": {
    "id": "S205482884",
    "display_name": "Biological Psychiatry",
    "issn_l": "0006-3223",
    "issn": [
      "0006-3223",
      "1873-2402"
    ],
    "type": "journal",
    "host_organization": "https://openalex.org/P4310320990"
  },
  "volume": "22",
  "issue": "1",
  "first_page": "35",
  "last_page": "42",
  "open_access": {
    "is_oa": false,
    "oa_status": "closed",
    "oa_url": null,
    "any_repository_has_fulltext": false
  },
  "concepts": [
    {
      "id": "C2777972943",
      "display_name": "Naltrexone",
      "level": 4,
      "score": 0.98446774
    },
    {
      "id": "C27081682",
      "display_name": "Placebo",
      "level": 3,
      "score": 0.7702904
    },
    {
      "id": "C2775962371",
      "display_name": "Opioid antagonist",
      "level": 5,
      "score": 0.6699975
    },
    {
      "id": "C71924100",
      "display_name": "Medicine",
      "level": 0,
      "score": 0.63308775
    },
    {
      "id": "C3019590667",
      "display_name": "Narcotic antagonist",
      "level": 5,
      "score": 0.5961997
    },
    {
      "id": "C2908647359",
      "display_name": "Population",
      "level": 2,
      "score": 0.5418911
    },
    {
      "id": "C2776885963",
      "display_name": "Antagonist",
      "level": 3,
      "score": 0.5223452
    },
    {
      "id": "C544821477",
      "display_name": "Weight loss",
      "level": 3,
      "score": 0.44742516
    },
    {
      "id": "C98274493",
      "display_name": "Pharmacology",
      "level": 1,
      "score": 0.43232504
    },
    {
      "id": "C2777383412",
      "display_name": "Antagonism",
      "level": 3,
      "score": 0.4305018
    },
    {
      "id": "C2910878864",
      "display_name": "Narcotic antagonists",
      "level": 5,
      "score": 0.426535
    },
    {
      "id": "C126322002",
      "display_name": "Internal medicine",
      "level": 1,
      "score": 0.37539783
    },
    {
      "id": "C511355011",
      "display_name": "Obesity",
      "level": 2,
      "score": 0.32062042
    },
    {
      "id": "C2778750930",
      "display_name": "(+)-Naloxone",
      "level": 4,
      "score": 0.17407122
    },
    {
      "id": "C99454951",
      "display_name": "Environmental health",
      "level": 1,
      "score": 0.05244723
    },
    {
      "id": "C204787440",
      "display_name": "Alternative medicine",
      "level": 2,
      "score": 0.051489323
    },
    {
      "id": "C170493617",
      "display_name": "Receptor",
      "level": 2,
      "score": 0.0
    },
    {
      "id": "C142724271",
      "display_name": "Pathology",
      "level": 1,
      "score": 0.0
    }
  ],
  "topics": [
    {
      "id": "T13338",
      "display_name": "Pharmacological Effects and Assays",
      "score": 0.9993
    },
    {
      "id": "T10814",
      "display_name": "Neuropeptides and Animal Physiology",
      "score": 0.9984
    },
    {
      "id": "T12539",
      "display_name": "Pharmacology and Obesity Treatment",
      "score": 0.9927
    }
  ],
  "created_date": null,
  "updated_date": null,
  "indexed_in": [],
  "landing_page_url": "https://doi.org/10.1016/0006-3223(87)90127-2",
  "pdf_url": null,
  "retrieved_date": "2025-07-30T15:01:19.076532",
  "source_database": "OpenAlex"
}